WESTPORT, Conn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that it plans to release financial results for the third quarter ended September 30, 2024, on Wednesday, October 30, 2024, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, October 30, 2024, at 5:00 p.m. ET. In conjunction with reporting third quarter 2024 results, CODI wi ...

WESTPORT, Conn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, today announced that its Board of Directors (the "Board") authorized the repurchase of up to $100 million of CODI's issued and outstanding common shares. Elias Sabo, CEO of Compass Diversified, commented: "This new $100 million repurchase program reflects our confidence in CODI's long-term strategy and our continued growth prospects." Under the authoriz ...

NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Compass, Inc. (NYSE: COMP), the largest residential real estate brokerage in the United States by sales volume1, announces its third quarter 2024 financial results will be released after market close on Wednesday, October 30, 2024. The company will host a conference call and webcast to discuss its results that afternoon at 5:00 p.m. ET / 2:00 p.m. PT. Call details are as follows: The conference call will be accessible online via the Compass Investor Relations website, ...

Core Insights - Compass Therapeutics, Inc. announced the acceptance of an abstract for poster presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting scheduled for November 8-10, 2024 [1] - The poster will focus on pharmacodynamic and response biomarkers in a Phase 1 trial of CTX-471, a novel anti-CD137 agonist antibody [2] Company Overview - Compass Therapeutics is a clinical-stage biopharmaceutical company focused on oncology, developing proprietary antibody-based therapeutics for multiple diseases [3] - The company's research emphasizes the interplay between angiogenesis, the immune system, and tumor growth, with a pipeline targeting critical biological pathways for effective antitumor responses [3] - Founded in 2014 and headquartered in Boston, Massachusetts, Compass aims to advance its product candidates through clinical development as standalone therapies and in combination with other proprietary antibodies [3]

WESTPORT, Conn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that its Board of Directors (the "Board") has declared a quarterly cash distribution of $0.25 per share on the Company's common shares (the "Common Shares"). The distribution for the three months ended September 30, 2024, is payable on October, 24, 2024, to all holders of record of Common Shares as of October 17, 2024. The Board also dec ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Fast-moving trending stocks can be difficult to enter at the right time, as they may lose momentum if future growth does not justify their high valuations [2] - A safer strategy involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Company Spotlight - Compass, Inc. (COMP) - Compass, Inc. has shown a significant price increase of 19.1% over the past four weeks, indicating growing investor interest [4] - Over the past 12 weeks, COMP's stock has gained 68.3%, demonstrating its ability to deliver positive returns over a longer timeframe [5] - COMP has a high beta of 2.92, suggesting it moves 192% higher than the market in either direction, indicating fast-paced momentum [5] - The stock has a Momentum Score of B, suggesting it is an opportune time for investment to capitalize on its momentum [6] Group 3: Earnings and Valuation - An upward trend in earnings estimate revisions has contributed to COMP earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - COMP is trading at a Price-to-Sales ratio of 0.58, indicating it is relatively cheap, as investors pay only 58 cents for each dollar of sales [7] Group 4: Additional Opportunities - Besides COMP, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies to help identify winning stock picks based on various investing styles [9]

Company Overview - Compass Group PLC (CMPGY) currently holds a Momentum Style Score of B, indicating a favorable position in momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [4] Performance Metrics - Over the past week, CMPGY shares increased by 0.15%, while the Zacks Retail - Restaurants industry rose by 1.8% [6] - In a longer time frame, CMPGY's monthly price change is 4%, outperforming the industry's 0.65% [6] - Over the past quarter, CMPGY shares have increased by 15.82%, and over the last year, they have gained 30.36%, compared to the S&P 500's 4.47% and 30.12% respectively [7] Trading Volume - CMPGY's average 20-day trading volume is 163,401 shares, which serves as a baseline for price-to-volume analysis [8] Earnings Outlook - In the last two months, two earnings estimates for CMPGY have been revised upwards, while none have been revised downwards, leading to an increase in the consensus estimate from $1.19 to $1.20 [10] - For the next fiscal year, one estimate has moved upwards with no downward revisions during the same period [10]

September 17th ended up being a really good day for shareholders of Compass Minerals International (NYSE: CMP ). Shares of the company spiked, rising by 21.1% for the day, after management announced preliminary Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential. Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P ...

Investors interested in Retail-Wholesale stocks should always be looking to find the best-performing companies in the group. Is Compass Group PLC (CMPGY) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Retail-Wholesale sector should help us answer this question. Compass Group PLC is a member of the Retail-Wholesale sector. This group includes 211 individual stocks and currently holds a Zacks Sector Rank of #9. The Zacks Sector Rank con ...

Core Viewpoint - Compass Group PLC (CMPGY) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are crucial for predicting near-term stock price movements [2][4]. - The recent upgrade reflects an improvement in Compass Group's earnings outlook, likely leading to increased buying pressure and a rise in stock price [3][5]. Earnings Estimate Revisions - Compass Group is projected to earn $1.20 per share for the fiscal year ending September 2024, representing a year-over-year increase of 13.2% [8]. - Over the past three months, the Zacks Consensus Estimate for Compass Group has risen by 0.8%, indicating a positive trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - The upgrade to Zacks Rank 2 places Compass Group in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].